NUCLEAR DEFECTIVE IL-33 DRIVES AN ANTI-TUMORIGENIC MICROENVIRONMENT IN GLIOBLASTOMA

Despite a sophisticated treatment regimen, including surgery, chemotherapy, and radiotherapy, survival outcomes for glioblastoma remain at a dismal 14.6 months. Multi-omics profiling have established that myeloid phagocytes drive glioma progression and contribute to therapeutic resistance. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Shyam V, Lun, Xueqing, Zhang, Jianbo, Ahn, Bo Young, Yu, Henry, Poole, Alisha, Dang, Ngoc Ha, Osz, Katalin, Chan, Jennifer, Robbins, Stephen M, Senger, Donna L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337527/
http://dx.doi.org/10.1093/noajnl/vdad071.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337527/
http://dx.doi.org/10.1093/noajnl/vdad071.038

Ejemplares similares